These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24976280)

  • 21. Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus.
    Besheer T; Elalfy H; Abd El-Maksoud M; Abd El-Razek A; Taman S; Zalata K; Elkashef W; Zaghloul H; Elshahawy H; Raafat D; Elemshaty W; Elsayed E; El-Gilany AH; El-Bendary M
    World J Gastroenterol; 2019 Mar; 25(11):1366-1377. PubMed ID: 30918429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.
    Ozel BD; Poyrazoğlu OK; Karaman A; Karaman H; Altinkaya E; Sevinç E; Zararsiz G
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):895-900. PubMed ID: 25951491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of fibronectin discriminant score for predicting liver fibrosis stages in chronic hepatitis C virus patients.
    Attallah AM; Abdallah SO; Attallah AA; Omran MM; Farid K; Nasif WA; Shiha GE; Abdel-Aziz AA; Rasafy N; Shaker YM
    Ann Hepatol; 2013; 12(1):44-53. PubMed ID: 23293193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of liver fibrosis in Egyptian chronic hepatitis B patients: A comparative study including 5 noninvasive indexes.
    Tag-Adeen M; Omar MZ; Abd-Elsalam FM; Hasaneen A; Mohamed MA; Elfeky HM; Said EM; Abdul-Aziz B; Osman AH; Ahmed ES; Osman GS; Abdul-Samie T
    Medicine (Baltimore); 2018 Feb; 97(6):e9781. PubMed ID: 29419671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.
    Holmberg SD; Lu M; Rupp LB; Lamerato LE; Moorman AC; Vijayadeva V; Boscarino JA; Henkle EM; Gordon SC;
    Clin Infect Dis; 2013 Jul; 57(2):240-6. PubMed ID: 23592832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
    Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
    Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C by Contrast-Enhanced Magnetic Resonance Imaging.
    Hako R; Kristian P; Jarčuška P; Haková I; Hockicková I; Schréter I; Janičko M
    Can J Gastroenterol Hepatol; 2019; 2019():3024630. PubMed ID: 31058108
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.
    Sterling RK; Lissen E; Clumeck N; Sola R; Correa MC; Montaner J; S Sulkowski M; Torriani FJ; Dieterich DT; Thomas DL; Messinger D; Nelson M;
    Hepatology; 2006 Jun; 43(6):1317-25. PubMed ID: 16729309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
    World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease.
    Naveau S; Raynard B; Ratziu V; Abella A; Imbert-Bismut F; Messous D; Beuzen F; Capron F; Thabut D; Munteanu M; Chaput JC; Poynard T
    Clin Gastroenterol Hepatol; 2005 Feb; 3(2):167-74. PubMed ID: 15704051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients.
    Ito K; Kuno A; Ikehara Y; Sugiyama M; Saito H; Aoki Y; Matsui T; Imamura M; Korenaga M; Murata K; Masaki N; Tanaka Y; Hige S; Izumi N; Kurosaki M; Nishiguchi S; Sakamoto M; Kage M; Narimatsu H; Mizokami M
    Hepatology; 2012 Oct; 56(4):1448-56. PubMed ID: 22535703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FibroScore for the non-invasive assessment of liver fibrosis in chronic viral hepatitis.
    Ashraf S; Ahmed SA; Ahmed J; Ali N
    J Coll Physicians Surg Pak; 2012 Feb; 22(2):84-90. PubMed ID: 22313643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients.
    Kim BK; Kim DY; Park JY; Ahn SH; Chon CY; Kim JK; Paik YH; Lee KS; Park YN; Han KH
    Liver Int; 2010 Apr; 30(4):546-53. PubMed ID: 20074094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States.
    Becker L; Salameh W; Sferruzza A; Zhang K; ng Chen R; Malik R; Reitz R; Nasser I; Afdhal NH
    Clin Gastroenterol Hepatol; 2009 Jun; 7(6):696-701. PubMed ID: 19514117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.
    Cross TJ; Calvaruso V; Maimone S; Carey I; Chang TP; Pleguezuelo M; Manousou P; Quaglia A; Grillo F; Dhillon AP; Dusheiko GM; Burroughs AK; Harrison PM
    J Viral Hepat; 2010 Aug; 17(8):546-54. PubMed ID: 19874477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CT texture analysis of the liver for assessing hepatic fibrosis in patients with hepatitis C virus.
    Lubner MG; Jones D; Kloke J; Said A; Pickhardt PJ
    Br J Radiol; 2019 Jan; 92(1093):20180153. PubMed ID: 30182750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients.
    Liu CH; Liang CC; Huang KW; Liu CJ; Chen SI; Lin JW; Hung PH; Tsai HB; Lai MY; Chen PJ; Chen JH; Chen DS; Kao JH
    Clin J Am Soc Nephrol; 2011 May; 6(5):1057-65. PubMed ID: 21393486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in Liver Stiffness and Noninvasive Fibrosis Scores in Egyptian Adolescents Successfully Treated with Ledipasvir-Sofosbuvir for Chronic Hepatitis C Virus Infection.
    Fahmy DM; Shokeir M; El Zeiny SM; Jonas MM; Abdallah A
    J Pediatr; 2021 Apr; 231():110-116. PubMed ID: 33347957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection.
    Sagrini E; Ardoino I; Marano G; Gianstefani A; Orlandini A; Sebastiani G; Donati G; Cucchetti A; Pelosi G; Ferrari C; Alberti A; Biganzoli E; Piscaglia F; Bolondi L
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1385-95. PubMed ID: 23839163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.
    Forns X; Ampurdanès S; Llovet JM; Aponte J; Quintó L; Martínez-Bauer E; Bruguera M; Sánchez-Tapias JM; Rodés J
    Hepatology; 2002 Oct; 36(4 Pt 1):986-92. PubMed ID: 12297848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.